Phase I clinical trial of an anti-vascular endothelial growth factor anti-angiopoietin 2 monoclonal antibody.
Phase of Trial: Phase I
Latest Information Update: 30 Apr 2012
At a glance
- Drugs Anti-vascular endothelial growth factor anti-angiopoietin-2 monoclonal antibody (Primary)
- Indications Cancer
- Focus Adverse reactions
- 30 Apr 2012 New trial record